New Times,
New Thinking.

Are Gen Z the loneliest generation in human history?

One in five Britons aged 18-24 have one or no close friends.


The number of children who say they feel lonely at school more than doubled between 2012 and 2018, and Britons aged 16-29 are more than twice as likely to report feeling often or always lonely as those aged over 70. 

A report by the think tank Onward found that one in five Britons aged 18-24 have one or no close friends, a proportion that has tripled in the past decade. 

Historically, people’s social networks have tended to shrink with age, but nowadays research shows that young people have fewer friends than older Britons. 

The evidence from the UK and other Western countries suggests that Generation Z – those born after 1997 – isn’t just the loneliest cohort in the country, they may be the loneliest generation in human history.

Sarah Dawood, senior associate editor speaks to writer Sophie McBain, who looked into the epidemic of loneliness amongst young people today for her New Statesman feature The lonely land.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU


Subscribers to the New Statesman can listen ad-free in our app. Download it on iOS or Android.

Not a regular podcast listener? Read our guide on how to listen to New Statesman

Content from our partners
Kickstarting growth: will complex health issues be ignored?
Nutrition must be central to Labour's health mission
How we can continue to innovate in the care of rare diseases